FDA.reportPublic FDA data

YESCARTA 200,000,000 CELLS in 68 mL Injection

RxCUI
1987407
RxNorm name
YESCARTA 200,000,000 CELLS in 68 mL Injection
Display name
YESCARTA 200,000,000 CELLS in 68 mL Injection
Full name
YESCARTA 200,000,000 CELLS in 68 mL Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125643Yescartaaxicabtagene ciloleucel351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YESCARTAAXICABTAGENE CILOLEUCELKite Pharma, Inc.9b70606e-b99c-4272-a0f1-b5523cce0c592026-08-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1987407

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9b70606e-b99c-4272-a0f1-b5523cce0c59YESCARTA 200,000,000 CELLS in 68 mL Injection [PSN] · 68 ML axicabtagene ciloleucel 2940000 CELLS/ML Injection [Yescarta] [SBD] · 68 ML Yescarta 2940000 CELLS/ML Injection [SY] · Yescarta 200,000,000 CELLS per 68 ML Injection [SY]421These highlights do not include all the information needed to use YESCARTA safely and effectively. See full prescribing information for YESCARTA. YESCARTA ® (axicabtagene ciloleucel) suspension for intravenous infusion Initial U.S. Approval: 201720260212